专利号:US-5405949-A 优先权日:1993-03-29 标题 :Process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acid 发明人:UNGARELLI FABRIZIO; PIANI SILVANO 权利人:ALFA WASSERMANN SPA 摘要:A process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acid in which the sulfate group is, entirely or in part, substituted with a nucleophilic group, is described. The process is carried out by treating glycosaminoglycans having heparin or heparan structure with a nucleophilic reagent in alkaline solution.
专利号:US-5410039-A 优先权日:1993-03-29 标题 :Process for the synthesis of glycosaminoglycans containing α-L-galacturonic acid substituted with nucleophilic groups in position 3 发明人:UNGARELLI FABRIZIO; PIANI SILVANO 权利人:ALFA WASSERMANN SPA 摘要:A process for the synthesis of glycosaminoglycans in which one of the α-L-iduronic-2-O-sulfate acid saccharide units, which is characteristic of glycosaminoglycans with heparin or heparan structure, has undergone a structural modification, entirely or in part, with transformation into α-L-galacturonic acid substituted in position 3 with nucleophilic groups, is described. The process is carried out by treating glycosaminoglycans having heparin or heparan structure with a nucleophilic reagent in alkaline solution.
专利号:US-9777022-B2 优先权日:2012-10-02 标题 :Process for the preparation of macrocyclic polyazacarboxylate ligands and chelates 发明人:MOORE DENNIS A; RAJAGOPALAN RAGHAVAN 权利人:MALLINCKRODT LLC; GUERBET SA 摘要:The present disclosure relates generally to a process for the synthesis of 1,4,7,10-tetraazacyclododecane ligands, chelates, and derivatives thereof. In particular, the present disclosure is directed to a process for the synthesis of 1,4,7,10-tetraaza-1,4,7,10-tetrakis(carboxymethyl)cyclododecane (DOTA) ligands, corresponding DOTA-metal chelates, and various derivatives thereof.
专利号:US-10221132-B2 优先权日:2016-10-24 标题:Process for the preparation of a sulfur-amine 发明人:BARATELLA MARCO; GABOARDI MAURO; CASTALDI GRAZIANO; OLDANI ERMINIO 权利人:CHEMELECTIVA SRL 摘要:The present invention relates to a process for the synthesis of cysteamine or a salt thereof.
专利号:US-2005080260-A1 优先权日:2003-04-22 标 题 :Preparation of prodrugs for selective drug delivery 发明人:MILLS RANDELL L; WU GUO-ZHANG 摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.
专利号:US-8877977-B2 优先权日:2011-11-25 标题 :Synthesis of polyalkylenepolyamines having a low color index by homogeneously catalyzed alcohol amination in the presence of hydrogen 发明人:STRAUTMANN JULIA; SCHAUB THOMAS; HUEFFER STEPHAN; MAAS STEFFEN; PACIELLO ROCCO 权利人:STRAUTMANN JULIA; SCHAUB THOMAS; HUEFFER STEPHAN; MAAS STEFFEN; PACIELLO ROCCO; BASF SE 摘要:Process for the preparation of polyalkylenepolyamines by homogeneously catalyzed alcohol amination, in which aliphatic amino alcohols are reacted with one another or aliphatic diamines or polyamines are reacted with aliphatic diols or polyols with the elimination of water in the presence of a homogeneous catalyst and in the presence of hydrogen gas. Polyalkylenepolyamines obtainable by such processes and polyalkylenepolyamines comprising hydroxy groups, secondary amines or tertiary amines. Uses of such polyalkylenepolyamines as adhesion promoters for printing inks, adhesion promoters in composite films, cohesion promoters for adhesives, crosslinkers/curing agents for resins, primers for paints, wet-adhesion promoters for emulsion paints, complexing agents and flocculating agents, penetration assistants in wood preservation, corrosion inhibitors, immobilizing agents for proteins and enzymes.
参考标题:New Series Of Morpholine And 1,4-Oxazepane Derivatives As Dopamine D4 Receptor Ligands: Synthesis And 3D-Qsar Model 作者:Karine Audouze,Elsebet østergaard Nielsen,Dan Peters |发布日期:2004.6.1 摘要:Since The Identification Of The Dopamine D(4) Receptor Subtype And Speculations About Its Possible Involvement In Schizophrenia, Much Work Has Been Put Into Development Of Selective D(4) Ligands. These Selective Ligands May Be Effective Antipsychotics Without Extrapyramidal Side Effects. This Work Describes The Synthesis Of A New Series Of 2,4-Disubstituted Morpholines And 2,4-Disubstituted 1,4-Oxazepanes
合成参考文献
摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118 参考文献:10.1007/bf01962705 摘要:Löscher W. Pharmacological, toxicological and neurochemical effects of Δ2(E)-valproate in animals. Pharmaceutisch Weekblad Scientific Edition. 1992 Jun;14(3):139–43. doi: 10.1007/bf01962705. 参考文献:10.1007/bf00634242 摘要:Dennis T, Curet O, Nishikawa T, Scatton B. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission. Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):225–34. doi: 10.1007/bf00634242. 参考文献:10.1007/bf02581350 摘要:Quatraro A, Consoli G, Stante A, Minei A, Ceriello A, Passariello N, Giugliano D. Impaired insulin secretion in human diabetes mellitus. Effect of pharmacological activation of gamma-aminobutyric acid system. Acta Diabetol Lat. 1986 Jan;23(1):23–8. doi: 10.1007/bf02581350. 参考文献:10.1007/bf00975049 摘要:Ghosh(née Biswas) S, Poddar MK. Higher environmental temperature-induced increase in body temperature: Involvement of serotonin in GABA mediated interaction of opioidergic system. Neurochemical Research. 1993 Dec;18(12):1287–92. doi: 10.1007/bf00975049.